Aura Biosciences, Inc. logo AURA - Aura Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $17.00 DETAILS
HIGH: $17.00
LOW: $17.00
MEDIAN: $17.00
CONSENSUS: $17.00
UPSIDE: 123.68%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.3 0 0 0.3 0 0.3 0 0 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.3) 0 0 (0.3) 0 (0.3) 0 0 (0.3) (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 28.0 21.9 22.2 22.9 23.3 22.3 17.0 16.9 17.1 20.3 15.4 15.1 14.4 13.2 11.3 9.5 8.3 8.0 6.4 6.6 4.2 3.5 2.9 5.3 6.3
SG&A Expenses 6.9 5.3 5.7 5.7 5.7 5.2 6.2 5.9 5.0 4.2 5.1 5.2 5.0 4.5 4.8 4.3 4.5 3.6 2.5 2.2 1.7 1.4 0.8 0.8 1.2
Other Expenses (0.3) 0 0 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 34.6 27.2 27.9 28.3 29.0 27.5 23.2 22.8 22.0 24.5 20.5 20.3 19.4 17.6 16.1 13.8 12.8 11.6 8.9 8.8 5.9 4.9 3.6 6.2 7.5
Operating Income
Operating Income (34.9) (27.2) (27.9) (28.6) (29.0) (27.8) (23.2) (22.8) (22.3) (24.8) (20.5) (20.3) (19.4) (17.6) (16.1) (13.8) (12.8) (11.6) (8.9) (8.8) (5.9) (4.9) (3.6) (6.2) (7.5)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0 0
Interest Income 1.2 1.5 1.8 1.7 1.6 2.0 2.3 2.5 2.7 2.6 2.0 2.0 2.0 1.1 0.5 0.3 0.0 0.0 0.0 0.0 0 0 0 0.0 0.0
Profitability
EBITDA (34.6) (27.0) (27.6) (26.7) (28.7) (25.5) (22.9) (22.4) (22.0) (21.7) (20.1) (20.0) (19.1) (17.3) (15.8) (13.5) (12.6) (11.4) (8.7) (8.6) (5.7) (4.7) (3.4) (6.0) (7.3)
EBIT (34.9) (27.2) (27.9) (27.0) (29.0) (25.8) (23.2) (22.8) (22.3) (22.0) (20.5) (20.3) (19.4) (17.6) (16.1) (13.8) (12.8) (11.6) (8.9) (8.8) (5.9) (4.9) (3.6) (6.2) (7.5)
Income Before Tax (33.7) (25.5) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.0) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (6.2) (7.5)
Income Tax Expense 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (8.1) (9.4)
Per Share Data
EPS (Basic) -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
EPS (Diluted) -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
Shares Outstanding 67.4 60.3 65.9 58.0 50.1 49.7 49.7 49.5 49.5 44.4 38.2 37.9 37.8 31.9 29.3 29.3 29.2 28.0 28.0 19.6 19.6 19.6 19.6 36.5 34.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 84.8 59.5 47.6 107.4 38.2 31.7 25.4 30.1 26.3 41.1 55.6 47.7 38.5 121.6 61.1 53.8 108.4 149.1 81.8 92.2 99.7 17.4
Short-Term Investments 29.9 84.7 114.3 69.9 89.8 119.4 149.0 157.3 176.6 185.1 93.5 114.3 135.0 67.2 50.4 68.3 24.9 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 3.8 5.5 6.1 6.6 1.8 1.8 3.4 7.5 2.3 3.8 4.5 3.3 4.1 5.7 4.0 4.5 4.4 0.1 0.1 0.6 0.0 0.0
Total Current Assets 118.5 149.7 170.1 184.0 134.5 160.6 183.5 195.6 212.2 231.8 153.9 166.2 179.1 196.7 115.9 127.7 139.6 153.7 83.5 92.9 100.7 18.5
Non-Current Assets
Property, Plant & Equipment 17.9 18.5 18.9 19.5 20.1 20.6 21.1 21.5 21.6 22.0 24.4 25.1 25.5 26.0 26.5 6.5 6.7 6.2 5.5 5.3 4.3 3.6
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0.8 0 0 0.8 0 0.8 0 0 0 0 0.8 0 0 0 0 0 0 0.1 0
Other Non-Current Assets 1.3 1.2 1.0 0.2 0.8 1.3 0.0 1.2 0.5 1.3 1.5 1.5 1.4 0.4 0.8 0.9 0.1 0.1 1.7 0.5 0 0.1
Total Non-Current Assets 19.2 19.7 19.9 20.4 20.9 21.9 21.9 22.7 22.8 23.3 25.9 26.5 26.9 27.2 27.2 7.4 6.8 6.3 7.2 5.8 4.4 3.6
Total Assets 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Current Liabilities
Account Payables 2.6 1.5 1.9 1.3 2.0 2.3 2.0 1.5 1.9 1.8 1.5 0.6 1.1 2.9 1.7 1.2 2.0 2.4 1.7 2.4 1.3 0.6
Short-Term Debt 3.3 3.2 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 0 0 0 0.4 0.0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 10.9 13.6 0.2 10.4 3.2 0.6 5.4 0.8 3.2 0.9 1.0 0.8 0.5 3.0 0.5 0.5 0.2 2.7 2.3 0.4 1.3 1.3
Total Current Liabilities 16.7 18.4 18.8 14.9 12.2 14.9 14.7 10.5 9.7 12.4 10.9 8.9 8.1 10.5 10.0 5.8 5.0 7.4 5.8 5.3 3.4 2.7
Non-Current Liabilities
Long-Term Debt 13.7 14.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.1 0 16.6 0.1 0.1 0.1
Total Non-Current Liabilities 13.7 14.1 14.5 14.9 15.3 15.6 16.0 16.3 16.6 16.9 17.2 17.4 17.7 17.9 18.1 0.1 0.3 0.4 17.2 0.8 0.6 0.1
Total Liabilities 30.4 32.5 33.4 29.8 27.4 30.5 30.7 26.8 26.2 29.2 28.0 26.3 25.8 28.4 28.1 5.9 5.3 7.7 23.0 6.1 4.0 2.7
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retained Earnings (514.1) (480.4) (454.9) (428.7) (401.7) (374.2) (348.4) (327.4) (307.0) (287.3) (265.2) (246.7) (228.4) (210.9) (194.3) (178.4) (165.0) (152.1) (140.5) (131.7) (122.8) (116.9)
Accumulated Other Comprehensive Income (0.2) (0.1) 0.1 0.0 0.1 0.3 0.6 (0.2) 0.0 0.5 (0.1) (0.2) (0.0) (0.1) (0.1) (0.1) (0.0) 0 0 0 0 0
Total Stockholders' Equity 107.2 136.9 156.7 174.6 128.0 152.0 174.7 191.5 208.8 225.8 151.7 166.4 180.3 195.6 115.1 129.1 141.1 152.3 67.7 92.6 101.1 19.4
Total Liabilities & Equity 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Debt Metrics
Total Debt 17.0 17.4 17.8 18.1 18.4 18.8 19.1 19.0 19.3 19.6 20.2 20.4 20.6 20.9 21.1 0.7 0.8 1.0 1.1 1.3 0.9 0.0
Net Debt (67.8) (42.1) (29.8) (89.3) (19.8) (12.9) (6.3) (11.0) (7.0) (21.5) (35.4) (27.3) (17.9) (100.7) (40.0) (53.2) (107.6) (148.1) (80.7) (90.9) (98.8) (17.4)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (6.2) (7.5)
Depreciation & Amortization 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Stock-Based Compensation 0 3.3 3.7 3.8 3.5 2.9 2.8 3.1 2.9 2.6 2.3 0 1.9 1.8 0 0 0 1.3 0 0.3 0.2 0.2 0.2 0.2 0.2
Change in Working Capital (0.4) 1.6 2.0 2.0 0.4 (0.9) 3.4 1.7 (6.8) 2.0 0.8 1.9 (0.5) (3.8) 3.5 1.5 (4.2) (2.0) (0.6) 1.8 0.4 0.7 (3.4) (0.7) (1.6)
Other Non-Cash Items 3.9 (0.0) 0.1 0.1 (0.1) (0.4) (0.7) (1.0) (1.2) 2.6 0.5 1.5 (0.7) 0.2 1.4 1.1 1.6 0.0 0.5 0.1 (0.0) (0.0) 0.0 0.6 0.7
Operating Cash Flow (29.9) (20.5) (20.1) (20.8) (23.4) (24.0) (15.3) (16.1) (24.5) (17.4) (15.4) (14.6) (16.4) (18.0) (10.8) (10.6) (15.2) (12.1) (8.7) (6.5) (5.1) (3.8) (6.6) (5.9) (8.1)
Investing Activities
Capital Expenditure (0.1) (0.2) (0.0) (0.0) (0.2) (0.3) (0.3) (0.5) (0.1) (0.3) (0.1) (0.2) (0.1) (0.4) (0.1) (0.1) (0.6) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Acquisitions 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 (74.0) (10.0) 0 (0.0) (20.0) (9.9) (29.2) (144.8) 0 0 (88.8) (48.5) 0 (46.4) (24.9) 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 55 30 30 30 30 30.0 30.2 30.3 38.7 55.0 21.7 21.6 22.1 32 18.0 3 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 54.9 29.8 (44.0) 20.0 29.8 29.7 9.9 19.8 9.4 (90.1) 21.6 21.4 (66.9) (16.9) 17.9 (43.4) (25.5) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 1.1 0 0 0 0 0 0 0 0.3 0 0.2 8.5 0 0 0 (0.0) 0 (0.3) 0.3 0.1 (0.1) 0.1 0.0
Financing Cash Flow 0.3 2.8 4.4 69.9 0.1 0.5 0.7 0.1 0.3 93.0 1.6 2.5 0.2 95.2 0.1 0.3 0.0 80.1 (1.1) (0.3) 87.5 5.1 4.8 0.1 0.0
Cash Position
Net Change in Cash 25.3 12.0 (59.8) 69.1 6.5 6.3 (4.7) 3.8 (14.8) (14.5) 7.9 9.2 (83.1) 60.3 7.4 (54.5) (40.7) 67.2 (10.4) (7.4) 82.3 1.2 (1.9) (5.8) (8.5)
Cash at Beginning 59.5 48.3 108.1 39.0 32.5 26.2 30.8 26.3 41.1 55.6 48.5 38.5 122.4 62.1 53.9 108.4 149.1 81.8 92.2 99.8 17.5 16.2 18.2 24.0 32.5
Cash at End 84.8 60.3 48.3 108.1 39.0 32.5 26.2 30.1 26.3 41.1 56.4 47.8 39.3 122.4 61.3 53.9 108.4 149.1 81.8 92.4 99.8 17.5 16.2 18.2 24.0
Free Cash Flow (30.0) (20.6) (20.2) (20.8) (23.5) (24.3) (15.6) (16.7) (24.5) (17.7) (15.5) (14.8) (16.5) (18.4) (10.8) (10.7) (15.8) (12.9) (9.3) (7.2) (5.2) (3.9) (6.7) (5.9) (8.6)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.3) 0 0 (0.3) 0 (0.3) 0 0 (0.3) (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (34.9) (27.2) (27.9) (28.6) (29.0) (27.8) (23.2) (22.8) (22.3) (24.8) (20.5) (20.3) (19.4) (17.6) (16.1) (13.8) (12.8) (11.6) (8.9) (8.8) (5.9) (4.9) (3.6) (6.2) (7.5)
Net Income (33.7) (25.6) (26.1) (27.0) (27.5) (25.8) (21.0) (20.3) (19.7) (22.1) (18.5) (18.3) (17.5) (16.6) (15.9) (13.5) (12.8) (11.6) (8.8) (8.9) (5.9) (4.9) (3.6) (8.1) (9.4)
EPS (Diluted) -0.50 -0.40 -0.40 -0.47 -0.55 -0.52 -0.42 -0.41 -0.40 -0.50 -0.48 -0.48 -0.40 -1.31 -0.54 -0.46 -0.44 -0.42 -0.32 -0.45 -0.30 -0.25 -0.19 -0.22 -0.27
Balance Sheet
Cash & Equivalents 84.8 59.5 47.6 107.4 38.2 31.7 25.4 30.1 26.3 41.1 55.6 47.7 38.5 121.6 61.1 53.8 108.4 149.1 81.8 92.2 99.7 17.4
Total Assets 137.7 169.4 190.0 204.4 155.4 182.5 205.3 218.3 235.0 255.1 179.8 192.7 206.0 223.9 143.1 135.0 146.4 160.0 90.7 98.7 105.1 22.1
Total Debt 17.0 17.4 17.8 18.1 18.4 18.8 19.1 19.0 19.3 19.6 20.2 20.4 20.6 20.9 21.1 0.7 0.8 1.0 1.1 1.3 0.9 0.0
Stockholders' Equity 107.2 136.9 156.7 174.6 128.0 152.0 174.7 191.5 208.8 225.8 151.7 166.4 180.3 195.6 115.1 129.1 141.1 152.3 67.7 92.6 101.1 19.4
Cash Flow
Operating Cash Flow (29.9) (20.5) (20.1) (20.8) (23.4) (24.0) (15.3) (16.1) (24.5) (17.4) (15.4) (14.6) (16.4) (18.0) (10.8) (10.6) (15.2) (12.1) (8.7) (6.5) (5.1) (3.8) (6.6) (5.9) (8.1)
Capital Expenditure (0.1) (0.2) (0.0) (0.0) (0.2) (0.3) (0.3) (0.5) (0.1) (0.3) (0.1) (0.2) (0.1) (0.4) (0.1) (0.1) (0.6) (0.8) (0.6) (0.7) (0.1) (0.1) (0.1) (0.1) (0.5)
Free Cash Flow (30.0) (20.6) (20.2) (20.8) (23.5) (24.3) (15.6) (16.7) (24.5) (17.7) (15.5) (14.8) (16.5) (18.4) (10.8) (10.7) (15.8) (12.9) (9.3) (7.2) (5.2) (3.9) (6.7) (5.9) (8.6)